Drugs / Salmeterol/Fluticasone Propionate
last change May 2013 re-read 2 minutes ago

Salmeterol/Fluticasone Propionate

Developed for
asthma

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01766843 Comparator Jan → May 2013 asthma Orion Corporation, Orion Pharma Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Salmeterol/Fluticasone Propionate “Bioequivalence Study Comparing Two Salmeterol/Fluticasone Propionate Dry Powder Inhalers, SF Easyhaler and Seretide Diskus 50/500 Mcg/Inhalation; Randomised, Double-blind,...” NCT01766843
Route Inhaled “2 inhalations as a single dose” NCT01766843